New Therapeutic Strategies and Drug Candidates for Neurodegenerative Diseases: p53 and TNF‐α Inhibitors, and GLP‐1 Receptor Agonists

@article{Greig2004NewTS,
  title={New Therapeutic Strategies and Drug Candidates for Neurodegenerative Diseases: p53 and TNF‐$\alpha$ Inhibitors, and GLP‐1 Receptor Agonists},
  author={Nigel H. Greig and Mark P. Mattson and Tracyann Perry and Sic L. Chan and Tony Giordano and Kumar Sambamurti and Jack Rogers and Haim Ovadia and Debomoy K. Lahiri},
  journal={Annals of the New York Academy of Sciences},
  year={2004},
  volume={1035}
}
Abstract: Owing to improving preventative, diagnostic, and therapeutic measures for cardiovascular disease and a variety of cancers, the average ages of North Americans and Europeans continue to rise. Regrettably, accompanying this increase in life span, there has been an increase in the number of individuals afflicted with age‐related neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and stroke. Although different cell types and brain areas are vulnerable among… 
Neuroprotective and neurotrophic actions of glucagon‐like peptide‐1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders
TLDR
Evidence supports a neurotrophic and neuroprotective role of GLP‐1 receptor (R) stimulation in an increasing array of cellular and animal neurodegeneration models as well as in neurogenesis, and focuses on the potential benefit of GLp‐1R stimulation as an immediately translatable treatment strategy for acute and chronic neurological disorders.
Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders
TLDR
The signaling pathways induced by TNF-α via its two receptors (TNFR1 and TNFR2), and their functions in neurodegenerative processes as in Alzheimer's disease, Parkinson’s disease, multiple sclerosis, and ischemic stroke are described.
Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.
TLDR
Exploring the articulation of AD pathogenic mechanisms by oxidative stress will provide clues for better understanding the pathogenesis and progression of this dementing disorder and for the development of effective therapies to treat this disease.
Tumor Necrosis Factor-Induced Cerebral Insulin Resistance in Alzheimer's Disease Links Numerous Treatment Rationales
TLDR
It is argued here that a number of independently developing approaches to therapy—including specific and nonspecific anti-tumor necrosis factor agents, apolipoprotein E mimetics, leptin, intranasal insulin, the glucagon-like peptide-1 mimetics and glycogen synthase kinase-3 (GSK-3) antagonists—are all part of an interlocking chain of events.
Role of Redox Signaling in Neuroinflammation and Neurodegenerative Diseases
TLDR
The mechanisms underlying the intracellular signaling pathways, especially ROS, involved in the expression of several inflammatory proteins induced by proinflammatory factors in brain resident cells are discussed.
Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model
TLDR
The results demonstrate that D-Ala2GIP has neuroprotective properties on key hallmarks found in AD, and shows that novel GIP analogues have the potential as a novel therapeutic for AD.
Neuroprotective properties of GLP-1: theoretical and practical applications
TLDR
The evidence for neuronal activity of GLP-1 is summarized and the limited data that currently exist on the therapeutic potential of GLp-1 in specific neurological and neurodegenerative conditions, namely Alzheimer's disease, Parkinson’s disease, Huntingdon’S disease, stroke and peripheral sensory neuropathy are examined.
Brief review Neuroprotective properties of GLP-1: theoretical and practical applications
TLDR
The evidence for neuronal activity of GLP-1 is summarized and the limited data that currently exist on the therapeutic potential of GLp-1 in specific neurological and neurodegenerative conditions, namely Alzheimer's disease, Parkinson’s disease, Huntingdon’S disease, stroke and peripheral sensory neuropathy are examined.
Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease.
TLDR
The main purpose of this review is to provide a comprehensive insight into the role of astrocytes in the neuroinflammatory pathogenesis of AD and to attenuating neuroinflammation in the early stage of AD.
...
...

References

SHOWING 1-10 OF 123 REFERENCES
A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β‐peptide
TLDR
Preclinical studies demonstrate the efficacy of a p53 inhibitor in models of stroke and neurodegenerative disorders, and suggest that drugs that inhibit p53 may reduce the extent of brain damage in related human neurodegenersative conditions.
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism
TLDR
It is reported that two novel synthetic inhibitors of the tumor suppressor protein p53, pifithrin‐α (PFT‐α) and Z‐1‐117, are highly effective in protecting midbrain dopaminergic neurons and improving behavioral outcome in a mouse model of Parkinson's disease.
Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases.
TLDR
Thalidomide was chosen for structural modification for the discovery of novel and more potent isosteric analogues with appropriate lipophilicity to insure high brain penetration in ENL and other neurodegenerative diseases.
A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.
TLDR
Recent trends in AD research are critically examined from molecular, genetic to clinical areas to lead to a deeper understanding of the pathobiochemical processes that occur in the AD brain in order to effectively diagnose and prevent their occurrence.
Caspases as treatment targets in stroke and neurodegenerative diseases
TLDR
The evidence and the potential importance of caspase inhibition to cerebral ischemia are reviewed and an emerging body of data implicating caspases in cell death accompanying neurodegenerative disorders is summarized.
Novel anti-inflammatory therapy for Parkinson's disease.
Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention
TLDR
Recent advances on the study of the role of microglia based on findings from animal and cell culture models in the pathogenesis of neurodegenerative diseases, with particular emphasis on Parkinson's disease are summarized.
Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior.
TLDR
The recent application of modern methods of molecular and cellular biology to the problem of brain aging is revealing a remarkable capacity within brain cells for adaptation to aging and resistance to disease.
...
...